News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Competitive Technologies, Inc. (CTCC) Announces Results of Pilot Trials Using Calmare(R) Medical Device With "Scrambler Therapy"(TM) Technology


5/18/2012 9:44:31 AM

FAIRFIELD, Conn., May 18, 2012 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) announced today the availability of two clinical trial abstracts announced by the American Society of Clinical Oncology (ASCO). Both abstracts indicate positive effects from the use of the Calmare® medical device with "Scrambler Therapy"™ technology. One study is on patients suffering from chemotherapy-induced peripheral neuropathy (CIPN) and the other is on patients suffering from post-herpetic neuropathy (PHN).

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES